CANADA MAKES GLOBAL GMP MANDATORY FOR PHARMA ACTIVE INGREDIENTS
May 1st, 2013
THE CANADIAN government has announced that from November 8, pharma manufacturers within Canada will have to abide by global good manufacturing practice (GMP) standards for their active ingredient production. Based on the International Conference on Harmonisation’s (ICH) Q7 Guidance, which has thus far been voluntary within Canada, the new rules would, claimed Canadian health minister Leona Aglukkaq, mean “the current high standards of drug safety in Canada are getting even stronger.”She noted: “Among other things, they create a new record-keeping ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.